Their technologies are aimed at low-cost manufacturing of antibodies, proteins, and vaccines, relying on proprietary core technologies and a continuous process intensification approach. Univercells operates as a campus of start-ups, with six businesses solving different parts of the same puzzle, meeting global demand for bioproduction. Each division of affiliates operates a different part of the healthcare value chain, through a distinct business model.